RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of various cancers. It also develops products in various stages, including RC-28E, a fu...
Industry: Biotechnology
Sector: Healthcare
Phone: 86 53 5611 3511
Address:
58 Middle Beijing Road, Yantai Development Zone Yantai Area of Shandong Pilot Free Trade, Yantai, China
